Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis

NCT00004428 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.

NCT NCT00004428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis
Lead sponsor
FDA Office of Orphan Products Development
Phase
Phase 1
Overall status
Completed
Start date
September 30, 1997
Completion date
October 31, 1999
Enrollment
35
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis